Possible Expansion of Byetta Use

Byetta, the type 2 diabetes drug, may soon be prescribed to treat certain drug addictions.

Byetta, the troubled type 2 diabetes drug, may soon be prescribed to a new set of patients. A recent study published online as a letter to the editor in the Journal of Molecular Psychiatry found that the injectable diabetes drug may be effective in treating certain drug addictions.

The study, using laboratory animals, found that Byetta, known clinically as Exendin-4, worked on suppressing the reward mechanism in the brain associated with cocaine use. The Vanderbilt researchers are cautiously optimistic that this study may lead to use of Exendin-4 to treat stimulant addictions in humans. This would possibly include amphetamine addictions. This study did not examine any links between Byetta and diseases such as pancreatic cancer and thyroid cancer.

The Vanderbilt study relating to using Byetta to treat stimulant drug addiction may be promising in developing future treatments for the future disease. However, Byetta has not been studied in humans for drug addiction. There is no data relating to side effects of Byetta use in patients suffering from drug addiction.

Byetta Subject of Litigation and FDA Concern

Recent reports that Amylin, the maker of Byetta, may have hidden data showing a link between the diabetes drug and pancreatic cancer has already caused the FDA to require Amylin to conduct a clinical trial on its new diabetes drug, Bydureon, because of concerns over possible increased risk of heart problems, thyroid cancer, and pancreatitis.

As recently as late September 2012 a lawsuit was filed in California alleging that Amylin failed to warn that Byetta was not safe for its intended use. The lawsuit alleges that Amylin willful and negligent in its failures to warn of the danger that Byetta may increase risk of pancreatic cancer.

Currently, the law firm of Slater Slater Schulman LLP is investigating the alleged links between Byetta and pancreatic cancer which surfaced as part of a UCLA study which found Byetta may raise the risk of pancreatic cancer almost threefold. If you or someone you love has suffered from pancreatic cancer after using Byetta, you can have a free consultation with an attorney at Slater Slater Schulman LLP by filling out the form on this page or calling (800) 251-6990.

Tagged with:

Leave a Reply


Anti-Spam Protection by WP-SpamFree

Follow Us on:

Contact Us

Privacy Policy

Please click here to view our privacy policy.